Alcon Basic Shares Outstanding 2019-2025 | ALC
Alcon annual/quarterly basic shares outstanding history and growth rate from 2019 to 2025. Basic shares outstanding can be defined as the number of shares held by shareholders including insiders but not including a company's treasury shares.
- Alcon basic shares outstanding for the quarter ending March 31, 2025 were $0.495B, a 0.26% increase year-over-year.
- Alcon basic shares outstanding for the twelve months ending March 31, 2025 were $1.979B, a 0.27% increase year-over-year.
- Alcon annual basic shares outstanding for 2024 were $0.494B, a 0.28% increase from 2023.
- Alcon annual basic shares outstanding for 2023 were $0.493B, a 0.33% increase from 2022.
- Alcon annual basic shares outstanding for 2022 were $0.491B, a 0.29% increase from 2021.
| Alcon Annual Basic Shares Outstanding (Millions of US $) |
|
|---|---|
| 2024 | $494 |
| 2023 | $493 |
| 2022 | $491 |
| 2021 | $490 |
| 2020 | $489 |
| 2019 | $488 |
| 2018 | $488 |
| Alcon Quarterly Basic Shares Outstanding (Millions of US $) |
|
|---|---|
| 2025-03-31 | $495 |
| 2024-12-31 | $494 |
| 2024-09-30 | $495 |
| 2024-06-30 | $495 |
| 2024-03-31 | $494 |
| 2023-12-31 | $493 |
| 2023-09-30 | $493 |
| 2023-06-30 | $493 |
| 2023-03-31 | $492 |
| 2022-12-31 | $491 |
| 2022-09-30 | $492 |
| 2022-06-30 | $492 |
| 2022-03-31 | $491 |
| 2021-12-31 | $490 |
| 2021-09-30 | $490 |
| 2021-06-30 | $490 |
| 2021-03-31 | $490 |
| 2020-12-31 | $489 |
| 2020-09-30 | $489 |
| 2020-06-30 | $489 |
| 2020-03-31 | $489 |
| 2019-12-31 | $488 |
| 2019-09-30 | $488 |
| 2019-06-30 | $488 |
| 2019-03-31 | $488 |
| 2018-12-31 | |
| 2018-09-30 | $488 |
| 2018-06-30 | $488 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $43.302B | $9.911B |
| Alcon Inc. researches, develops, manufactures, distributes, and sells a full suite of eye care products. Alcon operates within two segments, Surgical and Vision Care. The Surgical segment is focused on ophthalmic products for cataract surgery, vitreoretinal surgery, refractive laser surgery and glaucoma surgery, and includes implantables, consumables, and surgical equipment required for these procedures. The Vision Care segment comprises daily disposable, reusable and color-enhancing contact lenses, and a comprehensive portfolio of ocular health products, including products for dry eye, contact lens care, and ocular allergies, as well as ocular vitamins and redness relievers. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $199.668B | 87.45 |
| Thermo Fisher Scientific (TMO) | United States | $151.715B | 18.35 |
| Edwards Lifesciences (EW) | United States | $45.473B | 29.82 |
| IDEXX Laboratories (IDXX) | United States | $42.214B | 48.51 |
| DexCom (DXCM) | United States | $33.984B | 52.53 |
| IQVIA Holdings (IQV) | United States | $26.351B | 14.76 |
| Mettler-Toledo (MTD) | United States | $24.614B | 29.27 |
| STERIS (STE) | Ireland | $23.975B | 26.41 |
| Waters (WAT) | United States | $20.898B | 29.49 |
| SONOVA HOLDING (SONVY) | Switzerland | $18.583B | 0.00 |
| Hologic (HOLX) | United States | $14.336B | 15.58 |
| Sysmex ADR (SSMXY) | Japan | $10.191B | 28.91 |
| Penumbra (PEN) | United States | $10.026B | 78.69 |
| Masimo (MASI) | United States | $9.324B | 34.39 |
| Globus Medical (GMED) | United States | $8.112B | 19.33 |
| Teleflex (TFX) | United States | $5.426B | 8.96 |
| Glaukos (GKOS) | United States | $5.314B | 0.00 |
| TransMedics (TMDX) | United States | $4.703B | 102.24 |
| Integer Holdings (ITGR) | United States | $4.233B | 22.18 |
| PROCEPT BioRobotics (PRCT) | United States | $3.481B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.505B | 14.92 |
| Veracyte (VCYT) | United States | $2.151B | 30.18 |
| Nihon Kohden (NHNKY) | Japan | $2.052B | 23.53 |
| Elekta AB (EKTAY) | Sweden | $1.975B | 17.76 |
| Alphatec Holdings (ATEC) | United States | $1.861B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.384B | 0.00 |
| Artivion (AORT) | United States | $1.236B | 115.80 |
| Pulse Biosciences (PLSE) | United States | $1.150B | 0.00 |
| OPKO Health (OPK) | United States | $1.079B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.054B | 5.60 |
| Beta Bionics (BBNX) | United States | $0.827B | 0.00 |
| SiBone (SIBN) | United States | $0.805B | 0.00 |
| IRadimed (IRMD) | United States | $0.769B | 39.03 |
| RxSight (RXST) | United States | $0.611B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.576B | 8.96 |
| Delcath Systems (DCTH) | United States | $0.570B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.567B | 13.30 |
| OrthoPediatrics (KIDS) | United States | $0.515B | 0.00 |
| AxoGen (AXGN) | United States | $0.497B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.449B | 0.00 |
| NeuroPace (NPCE) | United States | $0.431B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.430B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.390B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.368B | 9.79 |
| Treace Medical Concepts (TMCI) | United States | $0.365B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.342B | 0.00 |
| 908 Devices (MASS) | United States | $0.249B | 0.00 |
| Neuronetics (STIM) | United States | $0.245B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.233B | 14.14 |
| Sight Sciences (SGHT) | United States | $0.217B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.213B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.200B | 0.00 |
| Inogen (INGN) | United States | $0.177B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.173B | 0.00 |
| CVRx (CVRX) | United States | $0.171B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.171B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.161B | 0.00 |
| LENSAR (LNSR) | United States | $0.155B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.140B | 0.00 |
| Accuray (ARAY) | United States | $0.133B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.116B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.102B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.091B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.081B | 49.20 |
| InspireMD (NSPR) | United States | $0.077B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.067B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.067B | 0.00 |
| Hyperfine (HYPR) | United States | $0.062B | 0.00 |
| Positron (POSC) | United States | $0.052B | 0.00 |
| Spectral AI (MDAI) | United States | $0.051B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.045B | 0.00 |
| Precision Optics (POCI) | United States | $0.036B | 0.00 |
| Envoy Medical (COCH) | United States | $0.033B | 0.00 |
| DarioHealth (DRIO) | United States | $0.031B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.030B | 0.00 | |
| Adagio Medical Holdings (ADGM) | United States | $0.020B | 0.00 |
| NexGel (NXGL) | United States | $0.018B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.012B | 0.00 |
| PAVmed (PAVM) | United States | $0.011B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.010B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.009B | 0.00 |
| Tenon Medical (TNON) | United States | $0.008B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.007B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.005B | 0.00 |
| Venus Concept (VERO) | Canada | $0.005B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.003B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Nuwellis (NUWE) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.001B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 16.29 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |